Ovarian neoplasm
MONDO:0021068A benign, borderline, or malignant neoplasm involving the ovary.
Also known as: neoplasm of ovary, neoplasm of the ovary, ovarian neoplasm, ovarian tumor, ovarian tumors, ovarian tumour, ovarian tumours, ovary neoplasm
2516 clinical trials for this condition and its sub-types, 78 tagged with Ovarian neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian neoplasm
-
Ovarian cancer 1,004 trials · 1,200 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Malignant non-epithelial tumor of ovary 1 trial · 9 incl. sub-types Sub-types →
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian sarcoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant ovarian cyst 1 trial
- Ovarian Wilms tumor 0 trials
- Ovarian adenosarcoma 0 trials
- Ovarian endometrioid adenocarcinofibroma 0 trials
- Ovarian lymphoma 0 trials
- Ovarian malignant mesothelioma 0 trials
-
Ovarian epithelial tumor 14 trials · 664 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Ovarian serous tumor 6 trials · 208 incl. sub-types Sub-types →
- Ovarian clear cell tumor 7 trials · 57 incl. sub-types Sub-types →
- Borderline epithelial tumor of ovary 6 trials · 16 incl. sub-types Sub-types →
- Ovarian mucinous neoplasm 1 trial · 16 incl. sub-types Sub-types →
- Ovarian seromucinous tumor 1 trial · 14 incl. sub-types Sub-types →
- Ovarian Brenner tumor 3 trials · 5 incl. sub-types Sub-types →
- Ovarian papillary tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian mucinous adenofibroma 0 trials Sub-types →
-
Ovarian germ cell tumor 9 trials · 13 incl. sub-types
4 sub-types
- Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types Sub-types →
- Ovarian teratoma 0 trials · 3 incl. sub-types Sub-types →
- Pediatric ovarian germ cell tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian cystic teratoma 0 trials Sub-types →
-
Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types
6 sub-types
- Malignant sex cord stromal tumor of ovary 0 trials · 5 incl. sub-types Sub-types →
- Ovarian granulosa cell tumor 2 trials · 5 incl. sub-types Sub-types →
- Ovarian sertoli-stromal cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Ovarian gynandroblastoma 0 trials
- Ovarian thecoma 0 trials
-
Ovarian benign neoplasm 1 trial
15 sub-types
- Meigs syndrome 0 trials
- Atypical Meigs syndrome 0 trials
- Benign ovarian mucinous tumor 0 trials
- Benign ovarian sex cord-stromal tumor 0 trials Sub-types →
- Benign struma ovarii 0 trials
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian clear cell adenofibroma 0 trials Sub-types →
- Ovarian endometrioid adenofibroma 0 trials Sub-types →
- Ovarian fibroma 0 trials
- Ovarian mucinous adenofibroma 0 trials Sub-types →
- Ovarian serous adenofibroma 0 trials Sub-types →
- Ovarian surface papilloma 0 trials
- Pseudo-Meigs syndrome 0 trials
- Rete ovarii cystadenofibroma 0 trials
- Serous or mucinous cystadenoma of childhood 0 trials Sub-types →
-
Ovarian melanoma 0 trials
-
Rete ovarii neoplasm 0 trials
3 sub-types
- Rete ovarii adenocarcinoma 0 trials
- Rete ovarii adenoma 0 trials Sub-types →
- Rete ovarii cystadenofibroma 0 trials
Most studied deeper sub-types
-
Can a targeted drug keep ovarian cancer at bay longer?
Disease control Not yet recruitingThis trial is testing whether a targeted therapy called raludotatug deruxtecan (R-DXd), given alone or with bevacizumab, can help people with newly diagnosed advanced ovarian cancer live longer without their cancer growing. Participants have already completed first-line platinum-…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Can an oral drug that starves tumors help Hard-to-Treat cancers?
Disease control Not yet recruitingResearchers are testing an investigational oral drug called catequentinib hydrochloride (AL3818) in adults with advanced or metastatic endometrial cancer, low grade serous ovarian cancer, soft tissue sarcoma, or glioblastoma. The trial has two parts: a phase 1b part to find safe …
Phase 1/2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug duo aims to outperform chemo in ovarian cancer
Disease control Not yet recruitingThis phase 3 trial tests whether a new drug called mocertatug rezetecan (Mo-Rez) combined with bevacizumab works better than standard chemotherapy plus bevacizumab for women with platinum-sensitive ovarian cancer. The study includes about 690 participants whose cancer has returne…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to stall ovarian cancer in patients without common DNA repair flaw
Disease control Not yet recruitingThis phase 3 trial tests whether the experimental drug mocertatug rezetecan (Mo-Rez), given alone or with bevacizumab, can delay cancer progression better than standard observation or bevacizumab alone in people with newly diagnosed advanced ovarian cancer that does not have a ho…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for advanced HER2 cancers? drug trial launches
Disease control Not yet recruitingThis early-phase study tests a drug called zanidatamab in 10 adults with advanced HER2-positive solid tumors (like endometrial, bladder, or pancreatic cancer) that have worsened after at least one prior treatment. Participants receive the drug by IV every two weeks. The main goal…
Phase 2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New spray chemotherapy trial targets Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis study tests a method called PIPAC, where the chemotherapy drug paclitaxel is turned into a pressurized spray and delivered directly into the abdomen. It is for women with ovarian cancer that has come back and no longer responds to platinum-based chemotherapy. The trial has t…
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Radioactive antibody aims to light up hidden solid tumors
Diagnosis Not yet recruitingResearchers are testing a new imaging agent called 111In-TJD-31 that targets placental alkaline phosphatase (ALPP), a protein found on many solid tumor cells but rarely in healthy adult tissue. The study enrolls 8 participants: 2 healthy volunteers who give blood samples and 6 pa…
Phase 1 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
AI reads tumor slides to match cancer patients with trials
Diagnosis Not yet recruitingMany cancer trials require patients to have specific molecular markers, so researchers test large numbers of people to find the few who qualify. This study evaluates FATHOM, an AI system that reads clinical trial records and routine tumor slides to predict which patients carry th…
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Can a simple blood test spot ovarian cancer before it starts?
Diagnosis Not yet recruitingThis study is looking at whether a blood test called Galleri can help detect ovarian cancer early in people with BRCA1 or BRCA2 gene changes, who are at higher risk. Participants will give a blood sample and answer questionnaires about their experience. The study will also check …
Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Blood test may spot ovarian cancer return months before scans
Diagnosis Not yet recruitingThis study looks at whether a specialized blood test can detect tiny bits of cancer DNA in the blood of women with advanced ovarian cancer after they finish initial treatment. Researchers will follow 300 women for up to 3 years, taking blood samples at key times. The goal is to s…
Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New blood test aims to catch ovarian cancer sooner
Diagnosis Not yet recruitingThis study will test a new blood test that looks for DNA changes to detect ovarian cancer, especially in early stages. Researchers will compare test results from 1,000 women with and without ovarian cancer to see how accurate it is. If it works well, it could lead to a simple scr…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Hypnosis may ease chemo anxiety in teens and young adults
Symptom relief Not yet recruitingThis study tests whether a single hypnosis session during chemotherapy can reduce anxiety and other side effects like nausea in young people with cancer. It includes 70 participants aged 15-49 with sarcoma, germ cell tumors, or breast cancer. Researchers will compare anxiety leve…
Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Doctors' teamwork under the microscope: can better meetings lead to better cancer care?
Knowledge-focused Not yet recruitingThis study looks at how doctors in tumor board meetings work together when discussing ovarian and uterine cancer cases. About 400 physicians will fill out surveys after each meeting to measure things like communication, teamwork, and decision-making. The goal is to understand wha…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to improve ovarian cancer surgery planning
Knowledge-focused Not yet recruitingThis study looks at how well different methods—imaging, a small camera surgery (laparoscopy), and open surgery (laparotomy)—agree on whether an ovarian mass can be completely removed. It will involve 28 women with primary ovarian cancer. The goal is to see if less invasive method…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple ultrasound score spot ovarian cancer?
Knowledge-focused Not yet recruitingThis study will check if an ultrasound scoring system called O-RADS can accurately tell benign from cancerous ovarian masses. About 80 women aged 18 to 70 with ovarian cysts or masses will get standard care, including detailed ultrasound and, if needed, surgery. Researchers will …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New study aims to catch ovarian cancer spread earlier with deeper tissue sampling
Knowledge-focused Not yet recruitingThis study tests whether removing a larger piece of the pelvic lining during surgery can find tiny cancer deposits that standard biopsies might miss. About 390 adults with early-stage ovarian or fallopian tube cancer will undergo this procedure. The goal is to improve staging acc…
Sponsor: Ospedale Santa Croce-Carle Cuneo • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC